Declines in Tapentadol Use in the US but Pronounced Regional Variation
There has been a substantial decline over the past decade in tapentadol distribution and prescribing. However, the substantial regional differences may warrant further attention by opioid stewardship programs.
Authors
- Brian J. Piper (ORCID: https://orcid.org/0000-0002-2295-445X)
- Ching Y. Low
- Kenneth L. McCall (ORCID: https://orcid.org/0000-0003-2061-108X)
Institutions
- Rutgers, The State University of New Jersey (US)
- Binghamton University (US)
- University of New England (US)
- Rutgers New Jersey Medical School (US)
- Geisinger Health System (US)
- Geisinger Commonwealth School of Medicine (US)
Publication Details
- Journal
- Pharmacy
- Published
- 2025-05-14
- DOI
- https://doi.org/10.3390/pharmacy13030067
- Citations
- 2
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- Eli Lilly and Company
- Pfizer